← Eichor
Study identifier: NCT05741125 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Improving Appetite Self-Regulation in African American Adults With Type 2 Diabetes

Condition: Type 2 Diabetes · Binge Eating  ·  Sponsor: University of North Carolina, Chapel Hill

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

The purpose of this 6-month randomized clinical trial is to examine the feasibility of recruitment, attendance, retention, program adherence, and satisfaction of a digital application designed, Centering Appetite to improve glucose scores (HbA1c) and binge eating in African American adults with type 2 diabetes. Intervention participants will receive type 2 diabetes education and web-based lessons on appetite self-regulation. Participants will also receive a Fitbit to monitor daily physical activity. The investigators will follow up with participants at six months.

This description comes directly from the study's public registry record.

Talk to the study team

Ramine Alexander, PhD, MPH  ·  704-250-5093  ·  raminea@unc.edu

Rachel Goode, PhD, MPH, LCSW  ·  919-962-6429  ·  rwgoode@email.unc.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Rachel W. GoodeKannapolis, North Carolina, United StatesNot Yet Recruiting
UNC Nutrition Research InstituteKannapolis, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05741125